David E. Lazar serves as Executive at TITAN PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, David E. Lazar has executed 10 insider transactions totaling $2.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 31, 2025 involved receiving (via award) 1,500,000 shares valued at $3.0M.
David E. Lazar currently holds 1,500,000 shares of TITAN PHARMACEUTICALS INC (TTNP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David E. Lazar has been a net buyer of TTNP stock. They have purchased $1.9M and sold $83.4K worth of shares.
David E. Lazar's most recent insider trade was on Dec 31, 2025, when they sold 1,500,000 shares at $2.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 21, 2025 | NBY | $0 | Award | 6,388,000 | $N/A | Discretionary |
| Jul 30, 2025 | CYCC | $83.4K | Sale | 6,750 | $12.36 | Discretionary |
| Apr 11, 2024 | OPGN | $0 | Award | 100,000 | $N/A | Discretionary |
| Jan 22, 2024 | MINM | $0 | Award | 25,000 | $N/A | Discretionary |
| Jul 26, 2023 | TTNP | $0 | Award | 100,000 | $N/A | Discretionary |
| Jul 7, 2022 | TTNP | $736.9K | Purchase | 744,294 | $0.99 | Discretionary |
| Jul 6, 2022 | TTNP | $897.8K | Purchase | 1,165,975 | $0.77 | Discretionary |
| Jul 6, 2022 | TTNP | $281.2K | Purchase | 315,921 | $0.89 | Discretionary |